SCHEMBL4836191

SCHEMBL4836191

CCC(C)C1CCCC(O)CCC1

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SHBG P04278 2/20 0.46
TSHR P16473 1/20 0.39
EPHX1 P07099 1/20 0.32
DPP4 P27487 1/20 0.30
DPP7 Q9UHL4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884590 0.96 SHBG (0.54) SHBGTSHREPHX1
SCHEMBL4845016 0.91 SHBG (0.54) SHBGTSHREPHX1
SCHEMBL1193094 0.88
SCHEMBL24920003 0.87 SHBG (0.39) SHBGTSHREPHX1DPP4DPP7
SCHEMBL21245994 0.87 SHBG (0.39) SHBGTSHREPHX1DPP4DPP7
SCHEMBL4843010 0.87 SHBG (0.39) SHBGTSHREPHX1DPP4DPP7
SCHEMBL2452534 0.86 SHBG (0.62) SHBGTSHRDPP4
SCHEMBL8415138 0.86 SHBG (0.62) SHBGTSHRDPP4
SCHEMBL132962 0.83
SCHEMBL4843531 0.83 SHBG (0.41) SHBGTSHREPHX1DPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1710223-B1 PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR UBE INDUSTRIES (JP) 2012-10-31 EP disclosed
US-7332632-B2 Method for producing aldehyde compound or ketone compound by using microreactor Ubē Industries, Ltd. (JP) 2008-02-19 US disclosed
US-20070149823-A1 Method for producing aldehyde compound or ketone compound by using microreactor UBE INDUSTRIES, LTD., A CORPORATION OF JAPAN (JP) 2007-06-28 US disclosed
EP-1710223-A1 PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR Ube Industries, Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149823-A1 Method for producing aldehyde compound or ketone compound by using microreactor ADH1C, ADH1A, ALDH1A1 SHBG 4583/4885TSHR 2363/4885EPHX1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.